Azathioprine is an immunosuppressant agent used to manage active rheumatoid arthritis and as adjunctive therapy in prevention of rejection of kidney transplants. Off label it is used to prevent rejection in solid organ (nonrenal) transplants; for Crohn's disease and ulcerative colitis.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Slow my MS progress | 27 |
|
|
|
6 | ||
| Slow my Devic's progress | 22 |
|
|
|
|
8 | |
| Other | 9 |
|
|
2 | |||
| Support another treatment | 2 | 0 | |||||
| slow my Devic's progress | 1 | 0 | |||||
| For Lupus SLE | 1 | 0 |
See all 64 patients currently taking Azathioprine
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
12 | 41% |
|
|
Other
|
8 | 28% |
|
|
Doctor's advice
|
6 | 21% |
|
|
Did not seem to work
|
4 | 14% |
|
|
Course of treatment ended
|
1 | 3% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.